RootK
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Abpro Bio makes compact machining centers, a type of computer-controlled metal-cutting machine tool used to shape and finish metal parts with precision.
Its machine tools are used by manufacturers that need automated metal-working equipment. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across three distinct business lines: its core machine-tool division, a biopharmaceutical drug-development unit focused on bispecific antibody candidates, and a semiconductor and secondary-battery equipment segment added through a subsidiary.
Summary is AI-generated and may contain errors · figures from DART filings
The company holds rights to develop and commercialize two bispecific antibody drug candidates across Asia, Russia and CIS countries, and the Middle East, acquired from Abpro Corporation, now Abpro Holdings, Inc.
RootK in five facts
What does RootK do?
Abpro Bio makes compact machining centers, a type of computer-controlled metal-cutting machine tool used to shape and finish metal parts with precision.
Where is RootK listed and in which sector?
RootK (Korean name: 루트K) trades under KRX code 195990 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Machinery.
How large is RootK?
Its market capitalisation was US$14M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were RootK's latest annual revenue and operating profit?
For fiscal year 2025, RootK reported revenue of US$24.1M, an operating loss of US$7M and a net loss of US$36.9M, per its annual report on DART (data retrieved from DART on 2026-09-17). Revenue was up 0.8% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-17
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Other market noticeOct 20
- Material event report (decision to redeem own convertible bonds early)
Route K Co., Ltd. (ticker 195990; filed under the Abpro Bio corporate record) resolved on August 28, 2026 to acquire US$362K in face value of its Series 19 private-placement convertible bonds before maturity from two bondholders, Baek Jae-wook and Baek Min-wook, leaving US$1.09M in face value outstanding.
Capital raise · Aug 28 - Trading suspension (share consolidation/split registration)
The KOSDAQ market will suspend trading in RootK Co., Ltd. common shares from July 10, 2026 until the day before the re-listing of the new share certificates, due to a share consolidation.
M&A · Jul 7 - [Amended] Material event report (convertible bonds)
RootK updated the terms of convertible bonds to raise US$1.36M, about 10.9% of its market value.
Capital raise · Apr 30 - [Amended] Material event report (convertible bonds)
RootK updated the terms of convertible bonds to raise US$2.04M, about 16.4% of its market value.
Capital raise · Apr 28 - [Amended] Material event report (convertible bonds)
RootK updated the terms of convertible bonds to raise US$1.03M, about 8.2% of its market value.
Capital raise · Apr 20 - [Amended] Material event report (convertible bonds)
RootK updated the terms of convertible bonds to raise US$2.03M, about 16.4% of its market value.
Capital raise · Apr 16 - [Amended] Material event report (convertible bonds)
RootK updated the terms of convertible bonds to raise US$2.04M, about 16.4% of its market value.
Capital raise · Apr 10 - [Amended] Change of largest shareholderOwnership change · Apr 1
- Change of largest shareholderOwnership change · Mar 31
- Securities issuance results (voluntary) (third-party placement)Capital raise · Mar 31
- [Attachment amended] Material event report (convertible bonds)Capital raise · Mar 18
- [Attachment amended] Material event report (convertible bonds)Capital raise · Mar 18
- Material event report (convertible bonds)
RootK disclosed convertible bonds to raise US$2M, about 16.4% of its market value.
Capital raise · Mar 16 - Material event report (convertible bonds)
RootK disclosed convertible bonds to raise US$2M, about 16.4% of its market value.
Capital raise · Mar 16 - Material event report (rights offering)
RootK disclosed a private placement (third-party allotment) to raise US$2.66M, about 21.8% of its market value.
Capital raise · Mar 16 - Agreement on change of control signed
RootK's controlling stake is set to change hands from Polymeth Investment Partnership to Returns Co., Ltd., in a deal worth US$2.72M.
Ownership change · Mar 13 - Trading suspension (share consolidation/split registration)M&A · Feb 12